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Whereas a wide variety of in vitro models have been developed and 
validated to assess the effect of specific food ingredients on the human gut 
microbiome, such models have only been developed and applied to a limited 
extent for companion animals. Since the use of pre- and probiotics to improve gut 
health is an emerging research topic in the field of companion animals and as dogs 
are often used as laboratory animals in developing and testing of pharmaceuticals, 
the current study aimed to establish an adequate canine in vitro model. This 
consisted of a four-stage reactor composed of a stomach and small intestinal 
compartment followed by a proximal and distal colon. This semi-continuous 
gastrointestinal tract model allowed a long-term, region-dependent and pH-
controlled simulation of the colon-associated microbial community of dogs. Upon 
reaching a functional steady state, the simulated canine microbial community 
composition proved to be representative of the in vivo situation. Indeed, the 
predominant bacterial phyla present in the in vitro proximal and distal colon 
corresponded with the main bacterial phyla detected in the fecal material of the 
dogs, resulting in an average community composition along the simulated canine 
gastrointestinal tract of 50.5% Firmicutes, 34.5% Bacteroidetes, 7.4% 
Fusobacteria, 4.9% Actinobacteria and 2.7% Proteobacteria. A parallel in vivo-in 
vitro comparison assessing the effects of fructo-oligosaccharides on the canine 
microbial community composition showed a consistent stimulation of 
Lactobacillus concentrations in the in vivo fecal samples as well as in the in vitro 
canine gut model. Furthermore, the in vitro platform provided additional insights 
about the prebiotic effect of fructo-oligosaccharides supplementation of dogs, 
such as a reduced abundance of Megamonas spp. which are only present in very 
low abundance in in vivo fecal samples, indicating an interesting application 
potential of the developed canine in vitro model in research related to 
gastrointestinal health of dogs.  
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INTRODUCTION 
The canine gastrointestinal tract harbors a complex community of bacteria, 
fungi, archaea and viruses, in the same order of magnitude as the host cells 
(Sender et al., 2016). With 109 – 1010 CFU/g, the amount of bacterial cells present 
in the large intestine of dogs outnumbers the other parts of the canine 
gastrointestinal tract (Honneffer et al., 2014). Similar to humans, the composition 
of the intestinal microbial community of dogs mainly consists of the bacterial 
phyla Firmicutes, Bacteroides, Proteobacteria, Fusobacteria and Actinobacteria in 
a similar distribution, thereby covering 99% of all bacteria in the canine intestine 
(Middelbos et al., 2007; Turnbaugh et al., 2009; Suchodolski, 2011; Schmitz and 
Suchodolski, 2016). It has been shown that the colon-associated canine 
microbiome plays a crucial role in food digestion, prevention from pathogenic 
infection, bioconversion of endogenous and exogenous compounds and 
immunomodulation (Garcia-Mazcorro et al., 2012). Therefore, much attention has 
recently been given to strategies that modulate the composition and metabolism of 
the canine intestinal microbial population in order to improve canine health (Pinna 
and Biagi, 2014). The most extensively studied approach for microbial community 
modulation in dogs is the use of prebiotics. Prebiotic compounds are classified as 
non-digestible substrates that are selectively used by the gut microbial 
community, thereby conferring a health benefit for the host (Gibson et al., 2017). 
Although the use of novel next-generation sequencing techniques gave rise to new 
insights regarding effects of prebiotics on microbial structure and function, final 
conclusions remain conflicting (Sunvold et al., 1995; Swanson et al., 2002a; 
Swanson et al., 2002b; Flickinger et al., 2003; Hesta et al., 2003; Suchodolski, 
2011; Beloshapka et al., 2013; Pinna and Biagi, 2014), emphasizing the need of 
additional studies to unravel the effect of prebiotics on the canine gastrointestinal 
community.  
As in vivo studies of dietary effects on the intestinal microbiota frequently 
encounter technical and ethical constraints, much attention has been given to the 
development of in vitro models. Whereas a wide variety of in vitro gut models to 
study the effect of test products, including prebiotics, on the gut microbiome have 
been developed and validated for human applications (Van den Abbeele et al., 
2010), the use of such models for companion animals such as dogs remains 
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limited. Moreover, since dogs are often used as laboratory animals in the 
development of pharmaceutical compounds, the establishment of an adequate 
canine in vitro gut model is of high interest. 
As reviewed by Suchodolski (Suchodolski, 2011), prebiotic in vitro studies 
in the field of companion animals are restricted to short term batch experiments 
(Sunvold et al., 1995; Barry et al., 2011). Such experiments are often not 
representative of the complex colonic environment as they lack pH control, 
repeated feeding cycles and refreshment of the media, and therefore do not 
simulate accurately the in vivo situation. This indicates a clear need for better 
designed in vitro gut models simulating the gastrointestinal tract of companion 
animals.  
In the current study, a dynamic in vitro gut model simulating the canine 
gastrointestinal tract was developed with focus on the colon-associated microbial 
community. To validate the developed canine gut model, a simultaneous in vivo-in 
vitro comparison was performed in which beagle dogs were subjected to common 
prebiotic treatment in vivo, whereas the fecal microbiota of the dogs was used as 
inoculum for a parallel in vitro prebiotic supplementation study. 
 
MATERIALS AND METHODS 
Simulator of the canine intestinal microbial ecosystem 
Considering the high similarity at the compositional and functional levels 
between the dog and human gut microbiota, the Simulator of the Human Intestinal 
Microbial Ecosystem (SHIME®) as described by Molly et al. (Molly et al., 1993) 
was adapted to simulate the canine gastrointestinal tract. The Simulator of the 
Canine Intestinal Microbial Ecosystem (SCIME™) set-up included four 
temperature-controlled reactors representing the different parts of the canine 
gastrointestinal tract, i.e. stomach, small intestine, proximal (PC) and distal colon 
(DC), as shown in Figure 1. The system was operated at 39°C and kept anaerobic 
by daily flushing with N2-gas. The first two reactors were of the fill-and-draw 
principle to simulate food uptake and digestion. In the stomach compartment a 
defined amount of simulated nutritional medium, composed of 9 g/L dog food 
(Hill’s Science plan adult advance Fitness Lamb and Rice), 4 g/L mucin, 0.5 g/L 
cystein (Sigma-Aldrich, Bornem, Belgium), 4 g/L special peptone and 1.5 g/L 
yeast extract (Oxoid, Aalst, Belgium), was added twice a day. Similarly, simulated 
pancreatic juice, composed of 2 g/L bile extract (Oxgall, Difco, Bierbeek, 
Belgium), 0.9 g/L pancreatin (Applichem, Zedelgem, Belgium) and 12.5 g/L 
NaHCO3 (VWR, Heverlee, Belgium) was added to the small intestinal 
compartment upon entering of the gastric suspension into this reactor. The last 
two reactor vessels, representing the canine large intestine, were continuously 
stirred with constant volume and pH control, and received the digested suspension 
from the small intestinal compartment at pre-defined intervals, with 12h in-
between each feeding cycle. The pH controllers, peristaltic pumps for liquid 
transfer and flushing equipment were incorporated in an automated setup 
controlled by LabVIEW software (TWINSHIME®, ProDigest, Zwijnaarde, 
Belgium). Residence times and pH were controlled to resemble in vivo conditions 
in the different parts of the canine gastrointestinal tract. Table 1 gives an overview 
of the parameters implemented in the SCIME™ model as compared to the 
SHIME® setup. 
In vivo validation study 
The animals were housed at the Faculty of Veterinary Medicine (Ghent, 
Belgium) according to the European animal welfare conditions. Prior to the study, 
dogs were adapted to the standard diet (Hill’s Science plan adult advance Fitness 
Lamb and Rice) during 14 days. During the in vivo trial, 10 beagle dogs (5 male, 5 
female) were fed the standard diet during a 10-day control period. This was 
followed by a 20-day treatment period, during which the standard diet was 
supplemented with 3% (w:w) fructo-oligosaccharides (FOS) from chicory root 
(Fibrulose®, Cosucra Groupe Warcoing S.A., Belgium). Four out of the ten dogs 
were randomly selected for validation of the in vitro SCIME™ model. During the 
control period, fresh fecal material from these four dogs was collected in an 
anaerobic container using an anaerobic bag (Anaerogen, Oxoid, Aalst, Belgium) 
for transport. Fecal material was processed within the hour after defecation as 
previously reported by De Boever et al. (De Boever et al., 2000) and used for 
inoculation of four parallel in vitro SCIME™ platforms. After inoculation, the 
canine microbial community was allowed to stabilize during 14 days to the in 
vitro reactor conditions. Following this stabilization period, the in vitro 
experiment consisted of a two-week control period in which the standard 
nutritional medium was administered, followed by a two-week treatment period 
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where the standard nutritional medium was supplemented with 3% FOS 
(Fibrulose®, Cosucra Groupe Warcoing S.A., Belgium), corresponding to a daily 
dose of 7.5 g/day. 
Sample collection 
Sampling of each reactor vessel of the SCIME™ was performed every two 
days during the stabilization, control and treatment periods. Liquid samples for 
subsequent analysis of microbial metabolic activity were immediately frozen at -
20°C, while pelleted cells (5 min, 9000g) originating from 1 mL liquid sample 
were frozen at -20°C for subsequent molecular analysis.  
During the in vivo trial, fecal material was collected 30 min after defecation 
every two days during the control and treatment periods and stored at -20°C prior 
to analysis. Fecal material for metabolic analysis was diluted in distilled water 
12.5% (w:v) and analyzed immediately. DNA extraction was performed directly 
on 0.5g fecal material. 
Microbial metabolic activity 
Short chain C2-C6 fatty acids (SCFA), including isoforms C4-C6, were 
measured by gas chromatography as described by Andersen et al. (Andersen et al., 
2014). Ammonium concentrations were determined by steam distillation as 
described by Possemiers et al. (Possemiers et al., 2004). 
Microbial community composition 
Total DNA was extracted using the method described previously by Van 
den Abbeele et al. (Van den Abbeele et al., 2018). The extracted DNA was 
dissolved in DNAse free water and stored at -20°C for subsequent analysis. 
Firstly, the microbial community composition was determined through Illumina 
sequencing.  The V1-2 region of the 16S rRNA gene was amplified as previously 
described (Camarinha-Silva et al., 2014) with some minor modifications. In the 
first 20 cycles of the polymerase chain reaction (PCR) the 16S rDNA target was 
enriched using the well-documented 27F and 338R primers (Lane, 1991; 
Etchebehere and Tiedje, 2005) as specified by Chaves-Moreno et al. (Chaves-
Moreno et al., 2015). Libraries were sequenced on an Illumina MiSeq platform. 
Furthermore, quantitative PCR (qPCR) for Lactobacillus spp. was performed as 
previously reported by Furet et al. (Furet et al., 2009). 
Statistical analysis 
Statistical data analyses for the in vivo - in vitro validation study was 
performed with the statistical software R, version 3.0.2. for Windows 
(http://www.r-project.org). Linear mixed model analysis was performed using the 
linear mixed-effects models (lme) package (Laird and Ware, 1982; Lindstrom and 
Bates, 1988). The restricted maximum likelihood (REML) approach was used to 
fit the mixed model (Pinheiro and Bates, 1996). The residuals were plotted against 
the fitted data. The distribution of the residuals and the normality was visually 
checked. Additionally, normality of the residuals was tested using the Shapiro-
Wilk Normality Test. In case of non-normality, the data were transformed to reach 
normality. The optimal transformation was determined using the box-cox 
transformation function (Box and Cox, 1964) in R. P-values to examine the effect 
of the prebiotic treatment were obtained using ANOVA of the mixed models. P-
values below 0.05 were considered statistically significant.  
For the in vivo and in vitro experiment, normality of the data and equality 
of the variances were assessed using the Kolgomorov-Smirnov test and Levene’s 
test. Comparison of normally distributed data was performed with Student’s test 
for pairwise comparisons. Comparison of means of non-normally distributed data 
was evaluated with nonparametric Kruskal-Wallis test. P-values below 0.05 were 
considered statistically significant.  
Bioinformatic processing of the Illumina sequencing data was conducted as 
previously described (Camarinha-Silva et al., 2014) with some modifications. 
Pair-end raw sequences were assembled according to Cole et al. (Cole et al., 
2014) and subsequently aligned (gotoh algorithm with the SILVA reference 
database) and pre-clustered (diff=2) using MOTHUR (Schloss et al., 2009). 
Obtained phylotypes were filtered to include only those present in an average 
abundance of ≥ 0.001% in all samples. Rarefaction curves and statistics were 
generated using the vegan package in R. All phylotypes were assigned a 
taxonomic affiliation based on RDPs Naïve Bayesian Classifier (RDP classifier) 
(Wang et al., 2007) applying an 80% of threshold. Overall, a total of 1,113,350 
reads were obtained (with an average of 34,792 reads per sample) that clustered 




Stability of canine microbial community in SCIME™  
Functional stability of the SCIME™ reactors was determined by plotting 
the correlation coefficients of microbial metabolic parameters between a sampling 
point and its preceding sampling point as a function of time during the 
stabilization and control periods (Figure 2). It was observed that the calculated 
correlation coefficients for the measured metabolic parameters, i.e. acetate, 
propionate, butyrate, total SCFA (sum of acetate, propionate, butyrate and 
branched SCFA) and ammonium, exceeded the minimal threshold of 80% within 
14 days of reactor operation. In the DC, acetate, propionate and total SCFA 
concentrations reached the 80% threshold after 7 days of operation, while a 
stabilization period of 14 days was needed in the PC. For butyrate, a stabilization 
period of 14 days was needed in both colon regions in order to reach the stability 
threshold of 80%. The fastest stability was reached for ammonium concentrations, 
as the 80% correlation was reached after 4 and 7 days for the PC and DC 
respectively.  
Microbial community composition in SCIME™ 
Predominant bacterial phyla present in the PC and DC of the SCIME™ 
consisted of Actinobacteria, Bacteroidetes, Firmicutes, Fusobacteria and 
Proteobacteria, which corresponded with the main bacterial phyla detected in vivo 
(Table 2). The Firmicutes phylum dominated the fecal material of the dogs with a 
relative abundance of 94.4% (ranging from 98.7% to 91.1%), followed by 
Actinobacteria with relative abundances ranging from 7.0% to 0.9%. Similarly, 
Firmicutes were the most abundant phylum in the simulated canine microbial 
community of the SCIME™, comprising 52.4% and 48.6% in the PC and DC 
respectively. Actinobacteria were equally enriched in the PC and DC of the 
SCIME™, resulting in similar relative abundances as observed in the fecal 
microbial community of the dogs. Further, as compared with the in vivo samples, 
the simulated canine microbial community of the SCIME™ was enriched in 
Bacteroidetes (40.1% in PC and 28.8% in DC as compared to 1.2% in vivo) and 
Proteobacteria (2.3% in PC and 3.2% in DC as compared to <0.1% in vivo) at the 
expense of Firmicutes levels. Furthermore, in the DC an enrichment of 
Fusobacteria was observed, as seen by an overall relative abundance of 14.5%.  
Within the Firmicutes phylum, the predominant bacterial phylotypes 
observed in the in vivo samples belonged to the genus Lactobacillus. In the 
simulated canine microbial community of the SCIME™, the Lactobacillus genus 
was also highly abundant, especially in the PC, highly similar to the in vivo 
microbiota (17.2% and 6.3% in PC and DC, respectively, as compared to 26.7% in 
vivo). Similarly, the bacterial phylotypes belonging to the Clostridium cluster XI 
group were enriched in vivo, while they were detected in lower concentrations in 
the PC and DC compartments of the SCIME™ model. The genera Clostridium 
cluster XIVa and Megamonas on the other hand were enriched in the in vitro 
simulation model as compared to the fecal material of the dogs.  
Effect of FOS supplementation on microbial community composition 
In vivo, the addition of FOS resulted in a strong and significant increase in 
Lactobacillus concentrations. This key effect of FOS in vivo was also observed in 
both the PC and DC of the in vitro SCIME™ model (Table 3). Furthermore, FOS 
supplementation resulted in a significant decrease in two bacterial phylotypes 
belonging to Clostridium cluster XI in vivo, while this was only observed in the 
PC for one of these phylotypes in vitro. Finally, slightly enhanced levels of the 
genus Collinsella, belonging the Actinobacteria phylum, and some bacterial 
phylotypes within the Bacteroidetes phylum were significantly enriched upon 
FOS administration in vivo, with similar effects being observed in vitro, though 
not reaching statistical significance. On the contrary, the simulated canine 
microbial community of the SCIME™ was characterized by some minor 
decreases in Bacteroides genera and in a significant decrease in Megamonas upon 
FOS supplementation, which were not observed in vivo. In the DC compartment 
of the SCIME™, a remarkable increase in several Allobaculum phylotypes was 
observed, which was not observed in the in vivo fecal samples.  
To confirm the results obtained through 16S-targeted Illumina sequencing, 
the most abundant bacterial genus, i.e. Lactobacillus spp., was quantified by 
qPCR (Figure 3). Lactobacillus concentrations significantly increased upon FOS 
supplementation in the PC of the SCIME™ model (p=0.040) as well as in the in 
vivo fecal samples (p=0.021). Also in the DC of the SCIME™ model an increase 




Microbial community activity in SCIME™ 
SCFA profiles of the four SCIME™ platforms during the control period 
revealed that the PC was characterized by a SCFA profile consisting of 41% 
acetate, 41% propionate, 15% butyrate and 2% branched SCFA, while in the DC a 
proportional ratio of 40% acetate, 37% propionate, 20% butyrate and 3% branched 
SCFA was observed (Table 4). In the DC, a shift towards increased butyrate 
concentrations was observed (p<0.001), mainly at the expense of propionate 
concentrations (p=0.083). Furthermore, absolute branched SCFA concentrations 
were significantly higher in the DC as compared to the PC (p<0.001). Similarly, 
ammonium concentrations were significantly enriched in the DC compartments as 
compared to the PC (p<0.001). 
FOS supplementation resulted in a significant increase in acetate, 
propionate and butyrate concentrations in both the PC and DC compartments of 
the SCIME™ model, with the strongest effects being observed for propionate 
concentrations (Table 4). In vivo, increases in the aforementioned SCFA were not 
detected and even a significant decrease in butyrate concentrations was observed 
upon FOS administration. In contrast to the non-branched SCFA, the branched 
SCFA significantly decreased upon FOS supplementation in both colon 
compartments of the SCIME™, thereby confirming the effects that were observed 
in vivo. Finally, ammonium production decreased significantly in PC as well as in 
DC, which was also observed in the fecal samples of in vivo experiment.  
 
DISCUSSION 
The aim of this research was to establish a continuous in vitro model 
simulating the canine gastrointestinal tract with focus on the colon-associated 
microbial community. Due to high similarities in microbial function and 
composition between the gastrointestinal tract of humans and dogs, the SHIME®, 
a validated in vitro model simulating the human gastrointestinal tract (Molly et al., 
1993), was adapted in order to meet the canine physiology in terms of feed 
composition and regimen, gastrointestinal regions, digestive enzymes, pH control, 
temperature, residence time and fecal inoculum applied.  
With respect to the simulated canine microbial community composition, it 
was observed that the PC and DC of the SCIME™ harbored distinct microbial 
communities. For the human in vitro simulation platform this region-dependency 
of the colon-associated microbial community in terms of functionality and 
composition has been extensively validated using colonic samples from sudden 
death victims and proved to be mainly attributed to substrate availability, pH, 
residence time and redox potential (Macfarlane et al., 1998). Although such an 
extensive validation for the dog has not been performed yet, the current study 
indicates that two distinct bacterial communities were sustained in the proximal 
and distal compartments of the SCIME™. While the PC was characterized by 
high abundance of members from the Prevotellaceae and Lactobacillaceae 
families, the DC was enriched in Fusobacteriaceae as well as species belonging to 
Allobaculum genus. It has been reported that Lactobacillaceae are more enriched 
in the proximal part of the canine intestine due to their resilience towards lower 
pH and higher bile salt concentrations, and due to the shorter residence times in 
the upper parts of the gastrointestinal tract (Perelmuter et al., 2008), thereby 
confirming data obtained in the current study. Furthermore, it is well described 
that the proximal microbial community is adapted towards saccharolytic 
fermentation due to influx of undigestible carbohydrates in this part of the large 
intestine (Macfarlane et al., 1992). For instance, several members of the 
Bacteroidetes phylum, including Prevotellaceae, have been associated with high-
fiber degradation potential (De Filippo et al., 2010), and therefore specifically 
colonize the proximal colon areas (Van den Abbeele et al., 2010). The distal colon 
on the other hand is generally characterized by a microbial community rich in 
species with specific metabolic functions, such as mucin (Van Herreweghen et al., 
2017) and protein degradation (Macfarlane et al., 1992). In the present study, the 
DC of the SCIME™ showed increased concentrations of branched SCFA and 
ammonium, which have been linked with proteolytic fermentation. However, also 
increased production of butyrate was observed in the DC of the simulated canine 
gastrointestinal tract, which could be linked with the specific enrichment of 
Allobaculum in this colonic area. Indeed, members of the Allobaculum genus have 
been reported as potent butyrate producers in the canine gastrointestinal tract 
(Greetham et al., 2004). The same butyrate producing functionality has been 
described in many members of Clostridium cluster XIVa in humans (Louis and 
Flint, 2009). Clostridium cluster XIVa was also enriched in the DC compartment 
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of the SCIME™ model during the current study, though to a much lower extent as 
compared to the canine-specific Allobaculum genus.  
Recent advances in molecular tools have greatly improved our knowledge 
of the canine colon-associated microbial community. Kim et al. (Kim et al., 2017) 
showed by using the Illumina Miseq platform that the canine microbial 
community composition consists on average of Firmicutes (64.2–73.3%), 
Bacteroidetes (17.3–19.9%), Proteobacteria (0.9–8.7%), Fusobacteria (0–13.6%) 
and Actinobacteria (0.6–1.5%). However, Garcia-Mazcorro et al. showed a more 
dominant presence of Firmicutes (75–98%) in the fecal community of dogs using 
454-pyrosequencing (Garcia-Mazcorro et al., 2012). These observed discrepancies 
might be explained by the molecular method used, which should be considered 
when abundances of gut microbiota are compared among different studies 
(Garcia-Mazcorro and Minamoto, 2013). While the Firmicutes phylum strongly 
dominated the canine feces in the current study, with a relative abundance of 
94.4%, the predominant bacterial phyla present in the PC and DC of the SCIME™ 
corresponded with the main bacterial phyla detected in the fecal material of the 
dogs, resulting in an average community composition along the simulated canine 
gastrointestinal tract of 50.5% Firmicutes, 34.5% Bacteroidetes, 7.4% 
Fusobacteria, 4.9% Actinobacteria and 2.7% Proteobacteria. Overall, all bacterial 
groups that were present in the fecal material of the dogs in the current study 
proliferated well in the in vitro environment, resulting in highly representative 
microbial communities along the colonic regions of the SCIME™ model. 
However, when comparing the fecal microbial composition in the current study 
with the in vitro results, the microbial community in the SCIME™ model was 
significantly enriched in Bacteroidetes and Proteobacteria at the expense of 
Firmicutes. A similar enrichment has been previously observed in human in vitro 
gut models (Rajilic-Stojanovic et al., 2010; Van den Abbeele et al., 2010) and 
could be partly associated with the absence of mucosal adhesion sites (Van den 
Abbeele et al., 2013). Indeed, it has been shown that inclusion of a mucosal 
environment in the SHIME® model prevented the wash out of typically mucin 
associated butyrate producers (Van den Abbeele et al., 2013) and could therefore 
also be an interesting extension of the SCIME™ platform. Finally, the microbial 
community in the SCIME™ model showed a specific enrichment of Megamonas 
species in both the PC and DC. As predominant members of the Veillonellaceae 
family, Megamonas species are known to produce propionate and butyrate from 
lactate (Lin et al., 2011). Furthermore, in dogs, Megamonas spp. have been 
described to be enhanced upon supplementation of the prebiotic FOS, indicating 
their potential beneficial effect on the canine gastrointestinal health (Beloshapka 
et al., 2013). The fact the in vitro model sustained the growth of Megamonas 
could potentially allow a better understanding of the functionality of this genus in 
the microbial community of the canine associated gastrointestinal tract.  
To assess the effect of a test product on intestinal microbial composition 
and functioning in vitro, the establishment of steady-state bacterial community 
prior to the actual start of the treatment is of utmost importance as stability of the 
microbial community guarantees that any effects observed during a specific 
treatment truly result from the administered test product (Van den Abbeele et al., 
2010). Results showed that functional stability of the microbial community in the 
SCIME™ model was reached after 14 days following inoculation, which nicely 
corresponded with the results obtaining with the SHIME® model for human 
applications (Possemiers et al., 2004; Van den Abbeele et al., 2010). Upon 
reaching a stable microbial community in the current study, treatment with FOS 
from chicory root was initiated for a duration of two weeks in a parallel in vitro-in 
vivo experiment. This non-digestible fiber has been well described for its prebiotic 
potential in both dogs (Swanson et al., 2002b; Pinna and Biagi, 2014) and humans 
(Van de Wiele et al., 2004; Grootaert et al., 2009). Although conflicting findings 
on the effect of prebiotic administration in dogs on markers of proteolytic 
fermentation have been described (Beynen et al., 2002; Flickinger et al., 2003; 
Propst et al., 2003), our study revealed a consistent reduction of ammonium and 
branched SCFA concentrations both in vivo as well as in vitro. Furthermore, a 
consistent stimulation of Lactobacillus concentrations was observed upon FOS 
supplementation in the in vivo fecal samples as well as in the PC and DC of the 
SCIME™ model. On the other hand, FOS supplementation resulted in increased 
acetate, propionate and butyrate concentrations in the simulated canine 
gastrointestinal tract, while fecal levels of the aforementioned SCFA were not 
affected and even slightly reduced. Though, it is well known that fecal SCFA are 
not fully representative for the in vivo situation, as they are absorbed along the 
colon by the host (Von Engelhardt et al., 1989). Furthermore, large inter-
individual variations often result in the absence of significant effects. Similarly, 
 
8 
some conflicting effects on microbial community composition were observed 
between the parallel in vitro and in vivo study. For instance, reduced levels of 
Megamonas spp. were observed in the SCIME™ model upon treatment with FOS, 
while fecal concentrations remained unaffected. However, the low abundance of 
this genus in the in vivo samples made significant observations difficult. Several 
studies reported increased fecal abundance of Megamonas spp. upon treatment 
with FOS (Beloshapka et al., 2013). However, fecal community composition does 
not reflect the in vivo situation, where specific microbes can thrive in specific 
areas of the gastrointestinal tract. In vitro studies could therefore help to unravel 
the health-related effects of specific bacterial genera on the host and to measure 
prebiotic effects at the site of fermentation.  
In conclusion, a dynamic in vitro gut model simulating the canine gastro-
intestinal tract was developed, with focus on the colon-associated microbial 
community allowing to culture the complex gut microbiota over a longer period 
under representative conditions of the different intestinal regions. Advanced 
molecular analysis demonstrated the colon-region specificity of the colonization 
process, with the PC being characterized by a saccharolytic microbial community, 
while the DC was enriched in species with specific metabolic functions such as 
butyrate production and protein degradation. Upon reaching a functional steady 
state, the simulated canine microbial community composition proved to be 
representative for the in vivo condition, though the absence of mucosal adhesion 
sites resulted in a specific enrichment of Bacteroidetes and Proteobacteria at the 
expense of Firmicutes. Furthermore, as the current study mainly focused on 
validation of the activity and composition of the colon-associated microbial 
community in the SCIME™ model, chemical assessment of the digesta at 
each step of the digestion process might be an interesting approach for 
further validation of the in vitro canine gut model. Overall, the in vitro 
platform provided additional insights in the prebiotic effect of repeated FOS 
supplementation in dogs, indicating an interesting application potential of the 
SCIME™ model in research related to gastrointestinal health in dogs. 
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Figure 1. SCIME™ reactor setup. Schematic overview of the SCIME™ 
(Simulator of the Canine Intestinal Microbial Ecosystem) simulating the full 
canine gastrointestinal tract. 
 
 
Figure 2. Stability of the Canine Microbial Community in SCIME™. 
Variability of microbial metabolic activity obtained in the SCIME™ during the 
stabilization (day 1-14) and control period (day 15-30) expressed as correlation 
between a sampling point and its preceding sampling point (%) for acetate, 
propionate, butyrate, total SCFA and ammonium concentrations in the proximal 
and distal colon (n=1). The threshold for stability was put at 80% (dashed line) 










Figure 3. Microbial community composition as assessed via qPCR. 
Lactobacillus concentrations (16S rDNA copies/ng DNA) as assessed via qPCR 
at the end of the control (C) and treatment (Tr) period with FOS in both the 
proximal (PC) and distal colon (DC) of the SCIME™ model, as well as in the 
fecal material of the dogs (in vivo). Statistically significant differences are 







Table 1. SCIME™ parameters. Reactor setup of the Simulator of the Canine Intestinal Microbial Ecosystem (SCIME™) including reactor volumes (mL), residence times 
(h) and pH compared to the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®) (Possemiers et al., 2004). 
 











Stomach 140 1 2.00 200 2 2.00 
Small intestine 200 4 6.80 200 4 6.80 
Proximal colon 100 6 5.60-5.90 500 20 5.60-5.90 
Transverse colon - - - 800 32 6.10-6.40 
Distal colon 167 10 6.65-6.90 600 24 6.60-6.40 
Feeding regimen 2x/day 3x/day 
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Table 2. Canine microbial community composition. Abundances of the dominant bacterial phylotypes belonging to the Firmicutes, Proteobacteria, Actinobacteria, 
Bacteroidetes and Fusobacteria phylum (% ± SEM) as assessed via 16S-targeted Illumina sequencing in samples collected from the SCIME™ during the control period in 
both the proximal (PC) and distal colon (DC), as well as in the fecal material of the dogs during the control period (n=4). Statistically significant differences from the samples 






% SEM % SEM % SEM 
Actinobacteria 4.9 1.0 4.9 1.0 3.8 0.6 
Bifidobacterium 1.0 0.3 1.0 0.2 0.5 0.1 
Coriobacteriaceae 3.8 0.7 4.0 0.7 3.6 0.7 
Bacteroidetes 40.1 b 0.8 28.8 c 1.9 1.2 a 0.2 
Bacteroides 10.5 b 0.6 10.5 b 1.8 0.3 a 0.1 
Prevotellaceae 29.5 b 1.3 18.2 c 1.5 0.8 a 0.2 
Uncultured Bacteroidetes 0.1 0.1 0.1 0.0 0.1 0.1 
Firmicutes 52.4 b 0.5 48.6 b 0.7 94.4 a 0.1 
Lactobacillus 17.2 a,b 1.5 6.3 b 0.4 26.7 a 4.1 
Streptococcus 0.1 0.1 <0.1 <0.1 5.0 2.1 
Blautia 0.7 0.2 1.0 0.4 1.5 0.3 
Clostridium cluster XIVa 0.6 0.1 1.1 0.2 <0.1 <0.1 
Clostridium cluster XI 0.9 b 0.1 1.1 b 0.1 17.3 a 2.4 
Uncultured Clostridiales 0.1 0.1 0.8 0.1 0.1 0.3 
Allobaculum 7.2 0.6 13.5 0.4 13.3 4.0 
Catenibacterium 0.1 <0.1 <0.1 <0.1 2.4 0.7 
Erysipelotrichaceae  0.1 <0.1 0.0 0.1 2.3 0.6 
Turicibacter 0.1 b <0.1 <0.1 b <0.1 14.8 a 3.3 
Uncultured Acidaminococcaceae 0.5 0.1 0.8 0.1 <0.1 <0.1 
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Megamonas 19.1 b 1.0 20.5 b 1.1 0.1 a 0.1 
Uncultured Firmicutes 5.8 a,b 0.4 3.3 b 0.3 11.1 a 1.9 
Fusobacteria 0.3 a 0.1 14.5 b 0.8 0.3 a 0.1 
Uncultured Fusobacteriaceae 0.3 a 0.1 14.5 b 0.8 0.3 a 0.1 
Proteobacteria 2.3 b 0.2 3.2 b 0.2 <0.1 a <0.1 
Sutterella 1.2 b 0.1 1.8 b 0.2 <0.1 a <0.1 
Anaerobiospirillum 1.0 b 0.2 0.3 a,b 0.1 <0.1 a <0.1 




Table 3. Microbial Community Shift upon FOS Supplementation. Increase or decrease in relative abundances of the dominant bacterial phylotypes belonging to the 
Firmicutes, Actinobacteria, Bacteroidetes and Fusobacteria phylum (%) as assessed via 16S-targeted Illumina sequencing at the end of the treatment period with FOS as 
compared to the control period in samples collected from the SCIME™ in both the proximal (PC) and distal colon (DC), as well as in the fecal material of the dogs (n=4). 
Statistically significant increases or decreases as compared to the control period are indicated with their p-value and are shown in bold when p<0.05. 
 
 In vitro In vivo 
 
PC (%) p-value DC (%) p-value % p-value 
Actinobacteria       
14_Collinsella +0.5 0.556 -0.4 0.750 +0.4 0.036 
Bacteroidetes       
38_Bacteroides -1.2 0.035 -0.1 0.819 <0.1 0.873 
65_Bacteroides -0.4 0.150 -0.1 0.028 <0.1 0.333 
123_Bacteroides <0.1 0.483 +0.1 0.335 +0.6 0.005 
95_Bacteroidetes <0.1 0.566 +0.2 0.381 +0.7 0.020 
Firmicutes       
1_Lactobacillus +7.9 0.042 +2.9 0.014 +18.3 0.002 
8_Clostridium XI -0.2 0.010 <0.1 0.744 -7.7 0.024 
15_Clostridium XI -0.2 0.193 -0.5 0.104 -3.2 0.014 
10_Allobaculum -1.3 0.104 +4.4 0.023 -0.3 0.778 
21_Allobaculum -0.5 0.099 +1.8 0.003 -0.1 0.897 
28_Allobaculum -0.3 0.104 +1.3 0.021 <0.1 0.977 
33_Allobaculum -0.2 0.191 +1.8 0.047 -0.1 0.522 
63_Allobaculum -0.1 0.208 +0.7 0.024 <0.1 0.946 
25_Megamonas -1.7 0.013 -2.1 0.030 +0.1 0.258 
Fusobacteria       




Table 4. Microbial Metabolic Activity. Average acetate (mM), propionate (mM), butyrate (mM), branched SCFA (mM) and ammonium (mg/L) concentrations over the 
control (C) and the treatment (TR) period in the proximal (PC) and distal colon (DC) of the SCIME™ model as well as in fecal samples from the in vivo experiment upon 
treatment with FOS. Data are presented as mean ± SEM. Statistically significant differences relative to the control period are indicated by their p-value (p<0.05). 
 
 In vitro PC In vitro DC In vivo 
 C TR p value C TR p value C TR p value 
Acetate 
(mM) 
39 ± 4 45 ± 5 0.018 39 ± 3 43 ± 4 0.040 55 ± 7 49 ± 12 0.066 
Propionate 
(mM) 
39 ± 3 60 ± 5 <0.001 36 ± 3 46 ± 3 <0.001 42 ± 7 41 ±10 0.526 
Butyrate 
(mM) 
14 ± 2 18 ± 4 0.011 19 ± 2 28 ± 2 <0.001 22 ± 9 15 ± 8 0.003 
Branched 
SCFA (mM) 
2.7 ± 0.1 2.1 ± 0.1 <0.001 3.1 ± 0.2 2.7 ± 0.1 <0.001 1.0 ± 0.3 0.5 ± 0.3 <0.001 
Ammonium 
(mg/L) 
427 ± 13 358 ± 9 <0.001 527 ± 17 449 ± 12 <0.001 292 ± 61 222 ± 63 0.002 
 
 
